Arntzen F C, Wilhelmsen T W, Løwenstein H, Gjesing B, Maasch H J, Strömberg R, Einarsson R, Backman A, Mäkinen-Kiljunen S, Ford A
Norwegian Medicines Control Authority, Oslo.
J Allergy Clin Immunol. 1989 Jan;83(1):66-82. doi: 10.1016/0091-6749(89)90479-x.
A selected candidate international standard preparation of birch (Betula verrucosa)-pollen extract was studied together with other birch-pollen extracts in a multinational study involving 20 laboratories in 11 countries. The biologic activity of the extract had previously been demonstrated in quantitative skin prick testing. The study methods comprised RAST inhibition, histamine release, quantitative immunoelectrophoresis, isoelectric focusing, and other methods. The results from RAST inhibition were calculated as parallel-line assays with statistical tests for linearity and parallelism. Analysis of variance was applied to test the significance of differences between potency estimates. In all assay methods, the candidate standard could be used to assign relative potencies to other birch-pollen extracts. The candidate standard was adequately stable during 36 months of storage at or below 5 degrees C. On the basis of this study, the World Health Organization has established the preparation as the International Standard for birch-pollen extract with assigned units of 100,000 IU per ampule.
在一项涉及11个国家20个实验室的多国研究中,对一种选定的候选国际标准桦树(疣枝桦)花粉提取物与其他桦树花粉提取物进行了研究。该提取物的生物活性此前已在定量皮肤点刺试验中得到证实。研究方法包括放射性变应原吸附试验(RAST)抑制、组胺释放、定量免疫电泳、等电聚焦及其他方法。RAST抑制试验的结果通过平行线分析进行计算,并对线性和平行性进行统计检验。应用方差分析来检验效价估计值之间差异的显著性。在所有检测方法中,候选标准品均可用于确定其他桦树花粉提取物的相对效价。该候选标准品在5摄氏度或更低温度下储存36个月期间稳定性良好。基于这项研究,世界卫生组织已将该制剂确立为桦树花粉提取物国际标准品,每安瓿指定效价为100,000国际单位(IU)。